Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
SCIENION logo — Global leader in precision dispensing. Molecular biology mee...

SCIENION

Global leader in precision dispensing. Molecular biology meets industrial automation.

Founded 2001 Germany Berlin, Germany 98 employees Venture round Total: $4.50M Biotechnology

General Information

Company Name SCIENION
Founded Year 2001
Location Germany Berlin, Germany
Employees 98
Industries Biotechnology
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with SCIENION. To contact SCIENION, visit scienion.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does SCIENION compare?

A PDF of SCIENION and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting SCIENION soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About SCIENION

SCIENION is a biotechnology startup founded in 2000, based in Germany. It is a global leader in precision dispensing, merging molecular biology with industrial automation. The company specializes in manufacturing robust, high-performance dispensing automation for precise deposition of biological content in ultra-low volumes, including oligonucleotides, proteins, antibodies, and glycans. Its non-contact technology, coupled with flexible software, is utilized from early R&D to mass production, enabling easy scale-up. SCIENION's portfolio also includes readers optimized for quantitative array reading, designed to surpass existing commercial readers. Through its subsidiary Cellenion, the company has patented a breakthrough technology called cellenONE, enabling high-throughput isolation and dispensing of single cells onto various substrates. In addition to its innovative technologies, SCIENION offers assay development and contract manufacturing services, covering the entire manufacturing process. The company's expansion was supported by a €4.50M Venture Round investment by IBB Invest, NRW BANK, Peppermint Group, and S-Venture Capital Dortmund in July 18, 2006.

Business keywords: Precision Dispensing, Molecular Biology, Industrial Automation, High Performance Dispensing Automation, Biosensors, Microarrays, Assay Development, Contract Manufacturing, Quantitative Array Reading, Single-Cell Dispensing, Wafer Prep, Surface Functionalization, Point of Care Testing, Immunoassays, Miniaturisation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round €4.50M 4
IBB Ventures NRW BANK Peppermint Group
IBB Ventures, NRW BANK +2
18 Jul 2006

SCIENION Alternatives & Competitors

SCIENION vs
Biofortuna
Biofortuna United Kingdom

Flexible and transparent support for life science innovators. Assay development, manufacturing and l...

Venture round
33 employees
Biotechnology, Health Care
Compare SCIENION vs Biofortuna

FAQ About SCIENION

Global leader in precision dispensing. Molecular biology meets industrial automation.
SCIENION was founded in 2001.
SCIENION is headquartered in Berlin, Germany.
SCIENION operates in Biotechnology. Its work centres on Precision Dispensing, Molecular Biology, Industrial Automation and High Performance Dispensing Automation.
SCIENION has approximately 98 employees.
SCIENION has completed 1 funding round, raising a total of $4.50M. The latest funding stage is Venture round.
Top alternatives and competitors to SCIENION include Biofortuna. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SCIENION and Biofortuna are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for SCIENION, https://bouncewatch.com/company/scienion, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes